Natalia Navarro
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
Journal: Experimental hematology & oncology
Published: December 13, 2023
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.
Journal: Science advances
Published: February 08, 2023
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.
Journal: Cellular and molecular life sciences : CMLS
Published: January 13, 2022
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.
Journal: International journal of molecular sciences
Published: October 26, 2021
Dickkopf Proteins and Their Role in Cancer: A Family of Wnt Antagonists with a Dual Role.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 19, 2021
Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands.
Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands.
Journal: British journal of cancer
Published: March 10, 2017
Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 15, 2016
Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma.
Journal: Stem cells international
Published: July 15, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026